MRK and ABBV Related Headlines
Go Back- Barclays launches U.S. biopharma coverage with four preferred picks
- This U.S. biotech stock is Bernstein's Top Pick for 2026
- Revolution Medicines stock rises on Merck acquisition talks
- Merck (MRK) in Talks to buy Revolution Medicines (RVMD) - FT
- Merck upgraded on post-Keytruda growth, AbbVie cut as upside baked in - Wolfe
- Trump to announce prescription drug price agreements
- Bernstein on AmericasMedicines.com: 'The Noise Starts, But Not (Yet) from Trump'
- Trump demands pharma CEOs lower drug prices within 60 days
- Trump Posts Letters to Regeneron, Merck, AstraZeneca, GSK, Pfizer, Novo Nordisk, Amgen, Bristol-Myears, AbbVie, Novartis, Gilead, J&J on Truth Social
- Lawmakers push to ban direct-to-consumer drug advertising, WSJ reports
